Paul Alan Brooke
Director/Board Member at Cerus Endovascular Ltd.
Paul Alan Brooke active positions
Companies | Position | Start | End |
---|---|---|---|
Cerus Endovascular Ltd.
Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 2016-11-17 | - |
Cerus Endovascular, Inc.
Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Director/Board Member | - | - |
Career history of Paul Alan Brooke
Statistics
International
United Kingdom | 2 |
United States | 2 |
Operational
Director/Board Member | 2 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Cerus Endovascular Ltd.
Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Cerus Endovascular, Inc.
Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Health Technology |
- Stock Market
- Insiders
- Paul Alan Brooke
- Experience